Stock Track | Doximity Plunges 8% Despite Strong Q2 Results as Growth Outlook Disappoints

Stock Track
Nov 07, 2025

Doximity, Inc. (DOCS) experienced a significant 24-hour plunge of 8.12% on Thursday, despite reporting better-than-expected second-quarter financial results for fiscal 2026. The stark contrast between the company's strong performance and the market's negative reaction has left many investors puzzled.

In its Q2 report, Doximity announced revenue of $168.525 million, surpassing the estimated $156.8 million. The company's adjusted earnings per share (EPS) came in at $0.45, beating the consensus estimate of $0.38. Additionally, adjusted EBITDA reached $100.8 million, significantly higher than the expected $87.1 million. These results demonstrate Doximity's solid performance for the quarter ended September 30.

However, the company's forward guidance seems to have spooked investors. Doximity forecasts Q3 revenue between $180 million and $181 million, which is only in line with analyst expectations. For the full fiscal year, the company projects revenue in the range of $640-646 million. This outlook suggests a potential slowdown in growth, which appears to be the primary driver behind the stock's sharp decline. The market's reaction indicates concerns about Doximity's ability to maintain its growth trajectory in upcoming quarters, overshadowing its strong Q2 performance and triggering a sell-off in after-hours trading.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10